- Home
- TRNR vs KTTA Comparison
TRNR vs KTTA Comparison
Compare TRNR & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRNR | KTTA |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 26.7M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TRNR | KTTA |
|---|---|---|
| Price | $1.09 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 101.7K | ★ 532.4K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,774,000.00 | N/A |
| Revenue This Year | $249.54 | N/A |
| Revenue Next Year | $304.32 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 207.36 | N/A |
| 52 Week Low | $0.83 | $0.28 |
| 52 Week High | $39.60 | $3.85 |
Technical Indicators
Market Signals| Indicator | TRNR | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 30.76 | 50.66 |
| Support Level | $0.83 | $1.09 |
| Resistance Level | $1.50 | $1.30 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 28.99 | 27.12 |
Price Performance
Historical ComparisonAbout TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).